Directory
>
Kleanthis Gabriel Xanthopoulos
Kleanthis Gabriel Xanthopoulos
Board Member | Connect Biopharma
California, United States
Kleanthis Gabriel Xanthopoulos
Summary
Kleanthis G. Xanthopoulos, Ph.D. is a distinguished entrepreneur and executive in the biopharmaceutical sector, with a robust track record spanning over two decades. He has a profound commitment to innovation, having founded multiple companies and successfully led them to public offerings. As the current Chairman and CEO of Shoreline Biosciences, he is at the forefront of advancing biotechnology solutions. Kleanthis has demonstrated exceptional skills in strategic alliances and venture capital, enabling him to forge valuable partnerships within the industry. His academic background in molecular biology and genetics complements his extensive practical experience. Notably, he has a keen interest in the intersection of science and business, which drives his passion for building transformative healthcare companies. His leadership roles on various boards reflect his influence and dedication to the life sciences community. Kleanthis is also known for his relationship-building skills, which have been pivotal in his career.
Kleanthis Gabriel Xanthopoulos
Work Experience
Board Member at
Connect Biopharma
November 2020 - Present
Chairman of The Board & CEO at
Shoreline Biosciences, Inc.
June 2020 - Present
Chairman, Stork Capital Life Sciences at
STORK CAPITAL PTE. LTD.
June 2020 - Present
Member of the Board of Directors at
Zosano Pharma
January 2013 - Present
co-founder, Member of the Board at
Senté
January 2007 - Present
Chief Executive Officer at
IRRAS USA Inc.
June 2015 - July 2021
Managing General Partner at
Cerus Dmcc
August 2015 - June 2020
Chairman of the Board of Directors at
Apricus Pharmaceuticals Usa, Inc.
November 2011 - June 2020
Member of the Board of Directors at
LABORATORI DERIVATI ORGANICI SPA
July 2016 - June 2017
Chairman of the Board at
Bioniz Therapeutics, Inc.
January 2016 - August 2016
Member of the Board at
Biotechnology Innovation Organization
September 2011 - May 2016
President & CEO at
Regulus LLC
November 2007 - June 2015
Member of The Board at
Biocom California
January 2006 - December 2013
General Partner at
Enterprise Partners Venture Capital
November 2006 - November 2007
Founder, President & CEO at
Anadys Pharmaceuticals
January 2000 - January 2006
Kleanthis Gabriel Xanthopoulos
Education
Karolinska Institutet , Associate Professor
Rockefeller University
Univ. of Stockholm, Ph.D.
Univ. of Stockholm, Master Of Science (M.Sc.)
Aristotle University, Thessaloniki, Greece, Bachelor Of Applied Science (B.A.Sc.)
Frequently Asked Questions about Kleanthis Gabriel Xanthopoulos
What is Kleanthis Gabriel Xanthopoulos email address?
Kleanthis Gabriel Xanthopoulos's primary email address is *********@shorelinebio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Kleanthis Gabriel Xanthopoulos work for?
Kleanthis Gabriel Xanthopoulos is a Board Member at Connect Biopharma.
Where Kleanthis Gabriel Xanthopoulos graduated from?
Kleanthis Gabriel Xanthopoulos holds a degree in Molecular Biology And Genetics from Karolinska Institutet .
How can I directly contact Kleanthis Gabriel Xanthopoulos?
To contact Kleanthis Gabriel Xanthopoulos directly, you can use the email address *********@shorelinebio.com. Complete contact information is available upon registration with Muraena.
Is Kleanthis Gabriel Xanthopoulos an immigrant?
Yes, Kleanthis Gabriel Xanthopoulos is an immigrant and currently based in United States
Who is Kleanthis Gabriel Xanthopoulos?
Kleanthis G. Xanthopoulos, Ph.D. is a distinguished entrepreneur and executive in the biopharmaceutical sector, with a robust track record spanning over two decades. He has a profound commitment to innovation, having founded multiple companies and successfully led them to public offerings. As the current Chairman and CEO of Shoreline Biosciences, he is at the forefront of advancing biotechnology solutions. Kleanthis has demonstrated exceptional skills in strategic alliances and venture capital, enabling him to forge valuable partnerships within the industry. His academic background in molecular biology and genetics complements his extensive practical experience. Notably, he has a keen interest in the intersection of science and business, which drives his passion for building transformative healthcare companies. His leadership roles on various boards reflect his influence and dedication to the life sciences community. Kleanthis is also known for his relationship-building skills, which have been pivotal in his career.
Kleanthis`s contact details
*********@shorelinebio.com
*********@sentelabs.com
*********@cerusadvisors.com
*************@zosanopharma.com